GENinCode (LON:GENI) Trading 13.6% Higher – Here’s What Happened

GENinCode Plc (LON:GENI)’s share price was up 13.6% during trading on Thursday . The stock traded as high as GBX 1.25 and last traded at GBX 1.25. Approximately 4,552,396 shares changed hands during trading, an increase of 39% from the average daily volume of 3,274,655 shares. The stock had previously closed at GBX 1.10.

GENinCode Stock Performance

The stock has a market capitalization of £3.41 million, a P/E ratio of -0.51 and a beta of 0.66. The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.28. The company’s 50-day moving average is GBX 2.23 and its two-hundred day moving average is GBX 2.40.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.